Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Journal of Cosmetic Dermatology|July 14, 2022
Multicenter evaluation of a topical hyaluronic acid serumDeanne Mraz Robinson, Janelle Vega, Melanie D Palm, et al.Deutsche Medizinische Wochenschrift (1946)|October 28, 1983
[Vitamin K deficiency hemorrhages in 4 exclusively breast-fed infants 4 to 6 weeks of age]A H Sutor, H Pancochar, H Niederhoff, et al.Arzneimittel-Forschung|January 1, 1980
Exercise induced changes of catecholamines and potassium in plasma of dogs after treatment with propranololA H Staib, E Appel, F Starey, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 18, 2014
Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013D Pereyaslov, P Rosin, D Palm, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 19, 2019
Efficacy, Patient-Reported Outcomes, and Safety for Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead LinesMelanie D Palm, Julius Few, Tapan Patel, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1995
Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha geneV N Gorelov, K Dumon, N S Barteneva, et al.Clinical Pharmacology and Therapeutics|October 1, 1991
AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic propertiesB Schulte, C Volz-Zang, E Mutschler, et al.European Journal of Biochemistry|June 24, 2000
Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptideC Loske, A Gerdemann, W Schepl, et al.Journal of Drugs in Dermatology : JDD|January 26, 2019
Final Data from the Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR)Melanie D. Palm, Joel Schlessinger, Valerie D. Callender, et al.Molecular and Cellular Biology|December 1, 1996
3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathwaysS Ludwig, K Engel, A Hoffmeyer, et al.Pageof 14